Wells Fargo’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18K | Sell |
4,492
-28,531
| -86% | -$114K | ﹤0.01% | 5366 |
|
|
2025
Q1 | $30.1K | Buy |
33,023
+1,451
| +5% | +$1.32K | ﹤0.01% | 5117 |
|
|
2024
Q4 | $87.5K | Buy |
31,572
+7,038
| +29% | +$19.5K | ﹤0.01% | 4780 |
|
|
2024
Q3 | $128K | Buy |
24,534
+1,821
| +8% | +$9.52K | ﹤0.01% | 4481 |
|
|
2024
Q2 | $101K | Buy |
22,713
+5,855
| +35% | +$26.1K | ﹤0.01% | 4575 |
|
|
2024
Q1 | $129K | Buy |
16,858
+2,164
| +15% | +$16.6K | ﹤0.01% | 4377 |
|
|
2023
Q4 | $62.6K | Buy |
14,694
+6,253
| +74% | +$26.6K | ﹤0.01% | 4771 |
|
|
2023
Q3 | $35.5K | Sell |
8,441
-4,399
| -34% | -$18.5K | ﹤0.01% | 4999 |
|
|
2023
Q2 | $71.5K | Buy |
12,840
+12,675
| +7,682% | +$70.6K | ﹤0.01% | 4963 |
|
|
2023
Q1 | $945 | Buy |
165
+3
| +2% | +$17 | ﹤0.01% | 6076 |
|
|
2022
Q4 | $170 | Buy |
162
+5
| +3% | +$5 | ﹤0.01% | 6342 |
|
|
2022
Q3 | $0 | Sell |
157
-20
| -11% | – | ﹤0.01% | 6656 |
|
|
2022
Q2 | $1K | Sell |
177
-2,778
| -94% | -$15.7K | ﹤0.01% | 6227 |
|
|
2022
Q1 | $12K | Sell |
2,955
-5,028
| -63% | -$20.4K | ﹤0.01% | 5854 |
|
|
2021
Q4 | $54K | Buy |
7,983
+7,935
| +16,531% | +$53.7K | ﹤0.01% | 5489 |
|
|
2021
Q3 | $1K | Hold |
48
| – | – | ﹤0.01% | 6387 |
|
|
2021
Q2 | $1K | Sell |
48
-1,655
| -97% | -$34.5K | ﹤0.01% | 6335 |
|
|
2021
Q1 | $34K | Sell |
1,703
-7,993
| -82% | -$160K | ﹤0.01% | 5634 |
|
|
2020
Q4 | $200K | Buy |
9,696
+3,583
| +59% | +$73.9K | ﹤0.01% | 4955 |
|
|
2020
Q3 | $161K | Buy |
+6,113
| New | +$161K | ﹤0.01% | 4893 |
|